Pulmonary toxicity of mitomycin

Aman U. Buzdar, Sewa S. Legha, Mario A. Luna, Charles K. Tashima, Gabriel N. Hortobagyi, George R. Blumenschein

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Abstract

Six patients with breast cancer developed pulmonary toxicity following mitomycin therapy. The presenting symptoms were shortness of breath and a dry cough. The radiological pictures varied from a normal chest x‐ray to extensive bilateral pneumonitis. The histological findings consisted of diffuse alveolar damage progressing to interstitial pulmonary fibrosis. Corticosteroid therapy resulted in complete resolution of pneumonia in one patient. Respiratory symptoms improved in 3 patients following discontinuation of the drug. Two patients with extensive bilateral pneumonitis, who were not treated with steriods, died of respiratory failure. Mitomycin‐induced lung toxicity appears to be reversible with the discontinuation of drug and the administration of corticosteroids. Lung biopsy is necessary in order to rule out other diagnoses.

Original languageEnglish (US)
Pages (from-to)236-244
Number of pages9
JournalCancer
Volume45
Issue number2
DOIs
StatePublished - Jan 15 1980

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Pulmonary toxicity of mitomycin'. Together they form a unique fingerprint.

Cite this